Related Experiment Video
Updated: Jul 27, 2025
06:20
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
Published on: October 4, 2022
2.8K
A pancreatic cancer mouse model with human immunity
Biorxiv : the Preprint Server for Biology
|June 9, 2023
Summary
A new mouse model develops metastatic human pancreatic cancer (PDAC) with a human immune microenvironment (TIME). This platform aids research into PDAC TIME and immunotherapy response.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDAC) exhibits a tumor immune microenvironment (TIME) that confers resistance to immunotherapy.
- Effective preclinical models are needed to study the human PDAC TIME and its influence on treatment response.
Approach:
- Developed a novel mouse model that generates metastatic human PDAC.
- This model is infiltrated by human immune cells, recapitulating the human PDAC TIME.
Key Points:
- The model successfully replicates the complex human PDAC tumor immune microenvironment.
- Enables in vivo studies of human PDAC and its immune interactions.
Conclusions:
- The novel mouse model offers a versatile platform for investigating the human PDAC TIME.
- Facilitates the study of PDAC response to various immunotherapies and treatments.
